Investigational drug Shows Survival Benefit For Some Leukemia Patients in Phase 3 study Dr. Kamal Kant Kohli14 Jun 2022 7:00 AM ISTAn investigational drug taken while undergoing chemotherapy demonstrated superior overall survival compared to chemotherapy alone in adult patients...
Time-restricted eating may lower CVD risk for older breast cancer survivors Dr. Kamal Kant Kohli13 Jun 2022 8:45 PM ISTOlder breast cancer survivors with cardiometabolic risk factors who restricted food intake to eight hours during the weekday, followed by 16 hours of...
PSA prostate cancer screening found more beneficial than previous estimates, especially for blacks Dr. Kamal Kant Kohli13 Jun 2022 8:00 PM ISTNew research led by investigators from Weill Cornell Medicine, Fred Hutchinson Cancer Center, University Hospitals Cleveland and Case Western Reserve...
Karkinos Healthcare unveils Advanced Center for Cancer Diagnostics and Research in Kochi Ruchika Sharma13 Jun 2022 1:00 PM ISTKarkinos Healthcare has installed the most advanced high-throughput HPV assay equipment Cobas 6800 in this center with the ability to test over 1200...
Radiotherapy not always needed for elderly women with low-risk luminal A breast cancer Dr. Kamal Kant Kohli12 Jun 2022 8:00 PM ISTElderly women with low-risk luminal A breast cancer can safely avoid radiotherapy with guidance from Ki67 proliferation marker screening, finds phase...
Radiotherapy not always needed for early breast cancer Dr. Nandita Mohan11 Jun 2022 10:30 AM ISTAccording to a new research, it has been found that older women with early-stage breast cancer may not need radiotherapy after undergoing surgery. ...
Oral pill improves care of patients with bone marrow cancer: Study Dr. Kamal Kant Kohli11 Jun 2022 9:15 AM ISTCHICAGO AND SAN ANTONIO: Momelotinib, an oral pill taken once a day, significantly improved outcomes of patients treated for myelofibrosis (MF), a...
Ibrutinib with Chemoimmunotherapy Improved Progression-Free Survival of Newly Diagnosed Mantle Cell Lymphoma Patients Dr. Kamal Kant Kohli10 Jun 2022 7:15 PM ISTCombination chemoimmunotherapy with the Bruton's tyrosine kinase (BTK) inhibitor ibrutinib demonstrated improved progression-free survival over...
USFDA nod to Alembic Pharma cancer drug Dasatinib Ruchika Sharma10 Jun 2022 12:58 PM ISTVadodara: Drugmaker, Alembic Pharmaceuticals Limited, today announced that the company has received tentative approval from the US Food & Drug...
Weight-loss surgery slashes cancer risk and mortality Dr. Nandita Mohan9 Jun 2022 10:00 AM ISTAccording to a new study presented at the American Society for Metabolic and Bariatric Surgery (ASMBS) Annual Meeting, individuals with obesity were...
New guidelines for pancreatic cancer screening released Dr. Kamal Kant Kohli8 Jun 2022 7:45 PM ISTBOSTON: By the year 2030, pancreatic cancer is expected to become the second most common cause of cancer deaths for both men and women in the United...
Weight-loss surgery cuts risk of developing colorectal cancer by more than a third Dr. Kamal Kant Kohli8 Jun 2022 7:30 PM ISTDALLAS: People who had weight-loss surgery were 37% less likely to develop colorectal cancer compared to individuals with obesity who did not have the...
